Abstract
We determined the rates of community-acquired pneumonia (CAP)-associated hospitalizations and complications in Athens, over a period covering 4 years before and 4 years after the implementation of the 7-valent pneumococcal vaccine (PCV7) in Greece. PCV7 had no impact on pediatric CAP rates, whereas there was an increase in CAP-associated complications.
Keywords:
children; pneumococcal vaccine; pneumonia.
© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: [email protected].
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Child
-
Child, Preschool
-
Community-Acquired Infections / epidemiology*
-
Community-Acquired Infections / prevention & control
-
Diagnostic Tests, Routine
-
Greece
-
Heptavalent Pneumococcal Conjugate Vaccine / administration & dosage*
-
Heptavalent Pneumococcal Conjugate Vaccine / immunology
-
Humans
-
Immunogenicity, Vaccine
-
Infant
-
Infant, Newborn
-
Pneumococcal Infections / epidemiology*
-
Pneumococcal Infections / immunology
-
Pneumococcal Infections / prevention & control*
-
Pneumonia / epidemiology*
-
Pneumonia / prevention & control
-
Retrospective Studies
-
Tertiary Care Centers
Substances
-
Heptavalent Pneumococcal Conjugate Vaccine